MedPath
TGA Approval

VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial (398632)

398632

VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial

Celltrion Healthcare Australia Pty Ltd

September 5, 2023

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/fe841d546e56b2f4e87fb0adc5a5314e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/5a6ad54ceab51c192cdc8b8d1a2fe661.pdf

Active Ingredients

Bevacizumab

© Copyright 2025. All Rights Reserved by MedPath
VEGZELMA bevacizumab 400 mg/ 16 mL solution for intravenous infusion, vial (398632) - TGA 批准文号 | MedPath